Overview A Study for Patients With Osteoporosis Status: Completed Trial end date: 2008-07-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the effect of injectable teriparatide to intranasal salmon calcitonin on lumbar spine bone mineral density, in the treatment of Chinese patients with established osteoporosis Phase: Phase 3 Details Lead Sponsor: Eli Lilly and CompanyTreatments: CalcitoninCalcitonin Gene-Related PeptideKatacalcinSalmon calcitoninTeriparatide